Physician profile
Donald Yang
NPI 1952882300
$789.39
in general payments reported to CMS, 2019-2025
9 companies · $58.27 in 2025
The $58.27 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.44 · 2021: $77.02 · 2022: $121 · 2023: $323 · 2024: $166 · 2025: $58.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $254.45 | 2021-2025 | Invisalign, Itero Element 5d Plus Lite |
| Straumann USA LLC | $156.46 | 2023-2024 | |
| Dentsply Sirona INC | $143.81 | 2023 | Implant Dentistry, Waveone Gold Conform Fit |
| A-Dec, INC. | $106.00 | 2022 | |
| Voco America INC. | $44.44 | 2019 | |
| Solventum Corporation | $28.88 | 2024-2025 | 3m Clinpro, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Henry Schein, INC. | $21.48 | 2021 | |
| 3m Company | $17.24 | 2023 | 3m Espe Filtek Supreme Ultra Universal Restorative |
| Ivoclar Vivadent, INC. | $16.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.